Abiopharma

🔍 Hewett Wayne M. (Director)

Company: WELLS FARGO & COMPANY/MN (WFC)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock, $1 2/3 Par Value (Direct)
  Date: 2026-04-01 | Code: H | shares_owned_after: 101.00
• Acquired 419 shares of Phantom Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 41,351.45 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3

Footnotes:

• F1: Each Phantom Stock Unit represents the right to receive one share of Wells Fargo & Company common stock.
• F2: Deferred compensation shares payable in a lump sum or installments based upon director's election.
• F3: Includes dividend equivalents reinvested in additional Phantom Stock Units.